AKEBIA THERAPEUTICS, INC. (AKBA) Free cash flow 2016–2025
AKEBIA THERAPEUTICS, INC. (AKBA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$67.7MFY2025 · since FY2016: $55.2M → $67.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $67.7M | +266.4% |
| FY2024 | -$40.7M | -74.0% |
| FY2023 | -$23.4M | +68.1% |
| FY2022 | -$73.3M | +71.0% |
| FY2021 | -$253.0M | -128.6% |
| FY2020 | -$110.7M | +58.1% |
| FY2019 | -$264.1M | -166.5% |
| FY2018 | -$99.1M | -71.5% |
| FY2017 | -$57.8M | -204.6% |
| FY2016 | $55.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More AKBA financial trends
AKBA RevenueAKBA Net incomeAKBA Net marginAKBA Gross profitAKBA Gross marginAKBA Operating incomeAKBA Operating marginAKBA Operating cash flowAKBA Capital expendituresAKBA Return on equityAKBA Stock buybacksAKBA Dividends paidAKBA Total assetsAKBA Total liabilitiesAKBA Shareholders’ equityAKBA overview →